Showing 321 - 340 results of 572 for search '"CYP1A2"', query time: 0.38s Refine Results
  1. 321

    Silymarin prevents acetaminophen-induced hepatotoxicity via up-regulation of the glutathione conjugation capacity in mice by Young Chul Kim, Jong Deok Na, Do Young Kwon, Jae Hak Park

    Published 2018-10-01
    “…Silymarin treatment did not induce proteins or activities of Cyp2e1, Cyp1a2, and Cyp3a11, the major cytochrome P450 subtypes responsible for the metabolic activation of APAP to a reactive metabolite, N-acetyl-p-benzoquinoneimine. …”
    Get full text
    Article
  2. 322

    Pharmacogenomic profile of a central European urban random population-Czech population by Riccardo Proietti, Geraldo A. Maranho Neto, Sarka Kunzova, Oriana Lo Re, Ari Ahola-Olli, Juho Heliste, Juan Pablo Gonzalez-Rivas, Manlio Vinciguerra

    Published 2023-01-01
    “…Blood DNA was extracted and 59 single nucleotide polymorphisms within 13 genes (BCHE, CYP1A2, CYP2C9, CYP2C19, CYP2D6, CYP3A5, F2, F5, IFNL3, SLCO1B1, TPMT, UGT1A1, VKORC1), associated to different drug metabolizing rates, were characterized by genotyping using a genome wide commercial array. …”
    Get full text
    Article
  3. 323

    Enantiospecific effects of ketoconazole on aryl hydrocarbon receptor. by Aneta Novotna, Martina Korhonova, Iveta Bartonkova, Anatoly A Soshilov, Michael S Denison, Katerina Bogdanova, Milan Kolar, Petr Bednar, Zdenek Dvorak

    Published 2014-01-01
    “…In primary human hepatocytes, both enantiomers preferentially induced CYP1A2 over CYP1A1 mRNA and protein, and the potency of (+)-KET was slightly higher as compared to (-)-KET. …”
    Get full text
    Article
  4. 324

    Critical appraisal and update on the clinical utility of agomelatine, a melatonergic agonist, for the treatment of major depressive disease in adults by Robert H Howland

    Published 2009-11-01
    “…Agomelatine is contraindicated in patients with impaired liver function and in patients taking drugs that potently inhibit CYP-1A2 metabolic enzymes. Because elevated liver enzymes are common, and there is a rare risk of more serious liver reactions, routine laboratory monitoring of liver function is recommended periodically throughout treatment. …”
    Get full text
    Article
  5. 325

    A Biomedical Investigation of the Hepatoprotective Effect of Radix salviae miltiorrhizae and Network Pharmacology-Based Prediction of the Active Compounds and Molecular Targets by Ming Hong, Sha Li, Ning Wang, Hor-Yue Tan, Fan Cheung, Yibin Feng

    Published 2017-03-01
    “…The action mechanism may relate with regulating the intracellular molecular targets such as PPARα, CYP1A2, and MMP2 for regulation of lipid metabolism, antioxidant and anti-fibrogenesis by these potential active ingredients. …”
    Get full text
    Article
  6. 326

    In vitro study of chlorine dioxide on porcine intestinal epithelial cell gene markers by Orsolya Palócz, Zoltán Noszticzius, Kristóf Kály‐Kullai, Emma Bradley, György Csikó

    Published 2022-03-01
    “…We determined the alterations in mRNA levels of inflammatory mediators, such as IL6, CXCL8/IL8, TNF, HSPA6 (Hsp70), CAT and PTGS2 (COX2); furthermore, the expression of three cytochrome genes (CYP1A1, CYP1A2, CYP3A29) were analysed by quantitative PCR method. …”
    Get full text
    Article
  7. 327

    Involvement of hepatic lipid droplets and their associated proteins in the detoxification of aflatoxin B1 in aflatoxin-resistance BALB/C mouse by Nour Hammoudeh, Chadi Soukkarieh, Denis J. Murphy, Abdulsamie Hanano

    Published 2020-01-01
    “…Finally, transcript levels of CYP1A2, CYP1B1, GSTA3 and EH1 genes were elevated in livers of high-dose mice. …”
    Get full text
    Article
  8. 328

    A modeling approach to evaluate the balance between bioactivation and detoxification of MeIQx in human hepatocytes by Victorien Delannée, Sophie Langouët, Nathalie Théret, Anne Siegel

    Published 2017-09-01
    “…Results Our results demonstrate that (1) the detoxification pathway predominates, (2) the ratio between detoxification and bioactivation pathways is not linear and shows a maximum at 10 µM of MeIQx in hepatocyte cell models, and (3) CYP1A2 is a key enzyme in the system that regulates the balance between bioactivation and detoxification. …”
    Get full text
    Article
  9. 329

    Multidirectional vector pathways of vitamin D metabolism as modifiers of its interaction with drugs by O.M. Nikolova, O.A. Yakovleva

    Published 2018-02-01
    “…In the metabolism of medicines, the following six are involved: CYP1A2, CYP2C19, CYP2C9, CYP2D6, CYP2E1, CYP3A4, which provide biotransformation of drugs through oxidation. …”
    Get full text
    Article
  10. 330

    Model Cell Lines and Tissues of Different HGSOC Subtypes Differ in Local Estrogen Biosynthesis by Renata Pavlič, Marija Gjorgoska, Tea Lanišnik Rižner

    Published 2022-05-01
    “…In addition, higher <i>HSD17B14</i> and <i>CYP1A2</i> expressions were observed in highly chemoresistant COV362 cells and platinum-resistant tissues compared to those in HIO-80 cells and platinum-sensitive tissues. …”
    Get full text
    Article
  11. 331

    Short Culture of Bovine Hepatocytes Biopsied from Dairy Cows as a Model for Toxicological Studies—CYP 1A1 Activity Response to Zearalenone Treatment by Justyna Barć, Jadwiga Flaga, Anna Kozubek, Zygmunt Maciej Kowalski

    Published 2023-08-01
    “…The expression of hepatocyte marker genes (<i>G6PC</i>, <i>ALB</i>, <i>CYP1A2</i>) was measured and found to be highest at 6 h post-isolation, with a subsequent decrease over time. …”
    Get full text
    Article
  12. 332

    Effect of guggulsterone, a sterol identified in Commiphora gileadensis (Becham), on the dengue virus enzymes: Pharmacokinetics, molecular docking and molecular dynamics simulations... by Jawaher Abdualbaqi Abdulhakim

    Published 2022-08-01
    “…The tested compound may inhibit CYP2C19 and CYP2C9 and cannot inhibit CYP1A2, CYP2D6, and CYP3A4. Guggulsterone was shown to have no hepatotoxicity, cytotoxicity, or mutagenicity effect. …”
    Get full text
    Article
  13. 333

    The reproductive inhibitory effects of levonorgestrel, quinestrol, and EP-1 in Brandt’s vole (Lasiopodomys brandtii) by Luye Shi, Xiujuan Li, Zhihong Ji, Zishi Wang, Yuhua Shi, Xiangyu Tian, Zhenlong Wang

    Published 2020-06-01
    “…However, quinestrol caused a greater degree of toxicity, as determined by visible liver damage and reduced expression of the detoxifying molecule CYP1A2. Of the remaining two fertility control agents, EP-1 was superior to levonorgestrel in inhibiting the secretion of follicle-stimulating hormone and causing reproductive inhibition. …”
    Get full text
    Article
  14. 334

    Case-only study of interactions between metabolic enzymes and smoking in colorectal cancer by Zhang Shuangshuang, Zhang Yongjing, Chen Kun, Jin Mingjuan, Fan Chunhong, Liu Bing

    Published 2007-06-01
    “…Our objective was to measure the interactions between common polymorphisms of P450 (CYP1A2, CYP1B1, CYP2E1), GSTM1 and T1, SULT1A1 and cigarette smoking in colorectal cancer (CRC).…”
    Get full text
    Article
  15. 335

    Aryl hydrocarbon receptor (AHR)-regulated transcriptomic changes in rats sensitive or resistant to major dioxin toxicities by Okey Allan B, Chen Hanbo, Boutros Paul C, Moffat Ivy D, Pohjanvirta Raimo

    Published 2010-04-01
    “…However, well-known AHR-regulated and dioxin-inducible genes such as <it>CYP1A1</it>, <it>CYP1A2</it>, and <it>CYP1B1 </it>remained fully responsive to TCDD in all strains/lines. …”
    Get full text
    Article
  16. 336

    Effects of Diabetes Mellitus Induced by Alloxan on the Pharmacokinetics of Metformin in Rats: Restoration of Pharmacokinetic Parameters to the Control State by Insulin Treatment by Myung G. Lee, Young H Choi, Inchul Lee

    Published 2008-03-01
    “…The increase in hepatic CYP1A2, 2B1, and 2E1, and decrease in hepatic CYP2C11 in DMIA rats was returned to the controls by insulin treatment. …”
    Get full text
    Article
  17. 337

    Dose-dependent exposure to indoxyl sulfate alters AHR signaling, sirtuins gene expression, oxidative DNA damage, and bone mineral status in rats by Malgorzata Karbowska, Krystyna Pawlak, Beata Sieklucka, Tomasz Domaniewski, Urszula Lebkowska, Radoslaw Zawadzki, Dariusz Pawlak

    Published 2024-01-01
    “…The exposure to 100 IS increased AhR repressor (AhRR)-CYP1A2 gene expression, which was associated with SIRT-1, SIRT-3 and SIRT-7 expression. …”
    Get full text
    Article
  18. 338

    Pharmacogenetics of Osteoporosis: A Pathway Analysis of the Genetic Influence on the Effects of Antiresorptive Drugs by Álvaro del Real, Carmen Valero, José M. Olmos, Jose L. Hernández, José A. Riancho

    Published 2022-04-01
    “…Several SNPs located in genes FDPS and FNTA were associated with the bisphosphonate-induced changes in hip bone mineral density (BMD), whereas polymorphisms of the PDSS1, CYP19A1, CYP1A1, and CYP1A2 genes were associated with SERM-induced changes in spine BMD. …”
    Get full text
    Article
  19. 339

    Synthesis, Characterization, and Pharmacokinetic Studies of Thiazolidine-2,4-Dione Derivatives by Bushra Ansari, Haroon Khan, Muhammad Saeed Jan, Khalaf F. Alsharif, Khalid J. Alzahrani, Umer Rashid, Abdul Saboor Pirzada

    Published 2023-01-01
    “…Drug metabolism of TZDs derivatives showed that C3 was identified as an inhibitor of CYP2C9 and C5 as an inhibitor of CYP1A2 and CYP2C19. Drug likeness properties indicate that C1 has only one violation of the Ghose rule while C3 has violations in the Ghose and Egan rules. …”
    Get full text
    Article
  20. 340

    The roles of CYP2C19 and CYP3A4 in the in vitro metabolism of β‐eudesmol in human liver: Reaction phenotyping and enzyme kinetics by Nadda Muhamad, Kesara Na‐Bangchang

    Published 2023-12-01
    “…Reaction phenotyping using human recombinant CYPs (rCYPs) and selective chemical inhibitors of CYP1A2, CYP2C9, CYP2C19, CYP2D6, and CYP3A4 was performed, and enzyme kinetics and metabolic stability were investigated using human liver microsome (HLM). …”
    Get full text
    Article